|
|
|
|
|
|
|
|
| |
| follow us on |
 |
 |
|
|
|
How to submit your abstract |
|
| |
|
 |
Read the following section to ensure your abstract falls into the conference’s Learning Objectives |
|
Read the Terms and Conditions for submitting an abstract |
|
Check the box at the bottom of the page, agreeing to the Terms and Conditions and click “Continue to Abstract Submission” |
|
| |
| Deadline |
| To have you abstract evaluated for presentation at the 5th Medication Safety Conference, you must submit your |
| abstract no later than May 31st, 2012. Any abstract received after this date will not be reviewed. |
|
| |
| |
| Suggested Topics |
Who should submit an Abstract? |
| |
|
|
Medication safety best practices |
|
Strategies for managing high-alert medications |
|
Use of technology to enhance medication safety |
|
Medication safety culture |
|
Measuring medication safety |
|
Trigger tools for medication safety |
|
Risk management- RCA and FMEA |
|
Performance improvement projects for a safer use of medications |
|
Medication safety in supply chain |
|
Managing adverse drug events |
|
| |
|
|
Pharmacists |
|
Physicians |
|
Nurses |
|
Students |
|
Healthcare Quality and Risk Specialists |
| |
Other healthcare professionals involved in medication safety |
| |
|
| |
|
|
| |
|
|
Terms & Conditions
|
| |
|
| Oral and Poster presentations: |
General Terms and Conditions: |
| |
|
|
4 abstracts will be selected for oral |
|
Oral presentations will include a15-minute presentation by one of the abstract authors. Presenters will be limited to a maximum of 15 slides. All oral presentations will be followed by questions from the audience. |
|
Posters will be presented on the 15- 16th of the November. Authors will be assigned a time period during which they are expected to be with their poster to answer questions from meeting attendees. |
| |
| |
Posters must be A1 size (59cm width x 84cm length) |
|
Abstracts should be 250 words in length excluding list of references. |
|
Any pharmaceutical acronyms in the title must be spelled out. |
| |
|
|
| |
|
|
Authors must demonstrate that rigorous scientific . |
|
Authors must demonstrate whether or not the research conducted was in any way supported by commercial organizations, including any grants or in-kind donations. |
|
Do not include acknowledgements or brand names in abstract. |
|
If your abstract is selected and you wish to present, one of the abstract authors will be required to register for the event before July 1st, 2012 after which your presentation will be cancelled; registering for the event is a separate and independent process. |
|
Letters regarding the acceptance/rejection will be emailed to the presenting author by June 21st, 2012. Rejected abstracts will not be reconsidered.
Abstracts submitted on paper or by fax will not be accepted. |
|
Abstracts without clear relevance to the event's learning objectives will not be reviewed or considered |
|
An author may submit up to two (2) abstracts. Any additional abstracts will not be reviewed. |
|
|
GUIDELINES
|
| |
|
| Criteria for a successful abstract: |
Common Reasons for Rejection: |
| |
|
|
Presentation Balance: Abstracts should not promote commercial services, companies or products. |
|
Relevance: Abstracts should provide material that is relevant to the conference’s learning objectives and suggested topics above. |
|
Scientific Quality: Abstracts should provide a detailed description of the scientific methods employed during your research (purpose, methods, results, conclusion) |
|
Appropriate Use of Language: Abstracts should be presented using scientific terminology and maintaining clarity. |
|
Resulting Impact on Patient Safety: Clearly state how your research benefits patient safety.
|
| |
|
|
| |
|
|
Promotion of commercial services, companies or products |
|
Lack of originality in research |
|
Lack of sufficient data |
|
Poor explanation of methodologies employed during research |
|
Re-submitting the same abstract |
|
Lack of adherence to Terms, Conditions and Guidelines |
|
Submitting more than two (2) abstracts. |
|
|
CANCELLATIONS
|
| |
| We require that all cancellations for abstract presentations are made in writing, no later than September 1st, 2012. Cancellations must be made by the primary author only. Send cancellation request to info@synovetics.com |
|
| |
|
| |
|